38 related articles for article (PubMed ID: 38656257)
1. Primary epithelioid inflammatory myofibroblastic sarcoma of the brain with EML4::ALK fusion mimicking intra-axial glioma: a case report and brief literature review.
Kim EE; Park CK; Kang KM; Kwak Y; Park SH; Won JK
J Pathol Transl Med; 2024 May; 58(3):141-145. PubMed ID: 38766740
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory Myofibroblastic Tumor After Receiving Treatment for Non-small Cell Carcinoma.
Parker NC; Singanallur P; Faiek S; Gao J; White P
Cureus; 2024 Apr; 16(4):e59359. PubMed ID: 38817466
[TBL] [Abstract][Full Text] [Related]
3. Intra-abdominal Inflammatory Myofibroblastic Tumour (IMFT)-Uncommon Entity.
Dwivedi S; Rakesh CR; Anand S; Dogra N; Singh BP
Indian J Surg Oncol; 2024 May; 15(Suppl 2):344-348. PubMed ID: 38817997
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Inflammatory Myofibroblastic Tumor of Rectosigmoid Junction: A Case Report and Review of the Literature.
Soti Khiabani M; Monajemzadeh M; Raji H; Zamani F; Vaseie M; Pak N
Iran J Pathol; 2024; 19(1):132-136. PubMed ID: 38864087
[TBL] [Abstract][Full Text] [Related]
5. Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report.
Tateishi Y; Okudela K; Kawai S; Suzuki T; Umeda S; Matsumura M; Kioi M; Ohashi K
Diagn Pathol; 2016 Nov; 11(1):132. PubMed ID: 27846861
[TBL] [Abstract][Full Text] [Related]
6. Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring
Wang Z; Geng Y; Yuan LY; Wang MM; Ye CY; Sun L; Dai WP; Zang YS
Front Oncol; 2022; 12():761558. PubMed ID: 35237506
[TBL] [Abstract][Full Text] [Related]
7. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
Parker BM; Parker JV; Lymperopoulos A; Konda V
J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
[TBL] [Abstract][Full Text] [Related]
8. A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib.
Liu W; Duan Q; Gong L; Yang Y; Huang Z; Guo H; Niu X
Invest New Drugs; 2021 Feb; 39(1):278-282. PubMed ID: 32915420
[TBL] [Abstract][Full Text] [Related]
9. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory Myofibroblastic Tumor of the Esophagus and Stomach Successfully Treated With ALK Inhibitor in a Pediatric Patient: A Case Report and Concise Review of Literature.
Billingsley BC; Chaudhary R; Morris MW; Cox JA; Camacho-Gomez SM; Varshney N
Int J Surg Pathol; 2024 Apr; ():10668969241246470. PubMed ID: 38656257
[TBL] [Abstract][Full Text] [Related]
11. Crizotinib in ALK
Theilen TM; Soerensen J; Bochennek K; Becker M; Schwabe D; Rolle U; Klingebiel T; Lehrnbecher T
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286567
[TBL] [Abstract][Full Text] [Related]
12. ALK-1-positive inflammatory myofibroblastic tumor of the thyroid complicated by Hashimoto's thyroiditis: report of a rare case and a literature review.
Li CF; Wu XL; Wang JJ; Wang K; Zhang SY; Huang JJ; Hu HZ; Zheng H
Diagn Pathol; 2020 May; 15(1):58. PubMed ID: 32430041
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
